EXPRESS: Application of the sigma metrics to evaluate the analytical performance of cystatin C and design a quality control strategy
Background: Sigma metrics are commonly used to evaluate laboratory management. In this study, we aimed to evaluate the analytical performance of cystatin C using sigma metrics and to develop an individualized quality control scheme for cystatin C levels. Methods: Bias was calculated based on the samples used for the external quality assessment. The coefficient of variation was calculated using 6 months of internal quality control (IQC) measurements at two levels, and desirable specification derived from biological variation was used as the quality goal. The sigma value for cystatin C was calculated using the above data. The IQC scheme and improvement measures were formulated according to the Westgard sigma standards for batch size and quality goal index (QGI). Results: The sigma values for cystatin C, for quality control levels 1 and 2, were 3.04 and 4.95, respectively. The 13s/22s/R4s/41s/8x multi-rules (N=4 or 2 with R=2 or 4), with a batch size of 45 patient samples, were selected as the IQC schemes for cystatin C. With different levels of cystatin C, the power function graph showed a probability for error detection of 94% and 100% and a probability for false rejection of 4% and 2%, respectively. According to the QGI of cystatin C, its precision needs to be improved. Conclusions: With a âdesirableâ biological variation of 6.50%, the Westgard rule 13s/22s/R4s/41s/8x (N=4 or 2 with R=2 or 4, batch size of 45) with high efficacy for determining the detection error is recommended for individualized quality control schemes of cystatin C.